These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1921807)

  • 61. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
    Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P
    Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945
    [No Abstract]   [Full Text] [Related]  

  • 62. The aminopyrine breath test, an inadequate early indicator of methotrexate-induced liver disease in patients with psoriasis.
    Williams CN; McCauley D; Malatjalian DA; Turnbull GK; Ross JB
    Clin Invest Med; 1987 Mar; 10(2):54-8. PubMed ID: 3581546
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA; Cera PJ; Mangan TF; Newman ED
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methotrexate: a perspective of its use in the treatment of rheumatic diseases.
    Willkens RF; Watson MA
    J Lab Clin Med; 1982 Sep; 100(3):314-21. PubMed ID: 7108346
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Limitations and risks of therapy of psoriasis with amethopterin and hydroxyurea].
    Ottolenghi F; Andreassi L
    G Ital Dermatol Minerva Dermatol; 1971 Sep; 46(9):385-96. PubMed ID: 4255617
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparison of methods for identifying early methotrexate-induced hepatotoxicity in patients with rheumatoid arthritis.
    Arias JM; Morton KA; Albro JE; Patch GG; Valdivia S; Greenberg HE; Christian PE; Datz FL
    J Nucl Med; 1993 Nov; 34(11):1905-9. PubMed ID: 8229232
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low-dose weekly oral methotrexate therapy for inflammatory arthritis.
    Boh LE; Schuna AA; Pitterle ME; Adams EM; Sundstrom WR
    Clin Pharm; 1986 Jun; 5(6):503-8. PubMed ID: 3720217
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transient increase of aminotransferases in RA patients treated with methotrexate.
    Lacki JK; Samborski W; Machiewicz SH
    Z Rheumatol; 1993; 52(4):232-5. PubMed ID: 8212923
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Methotrexate therapy in rheumatoid arthritis. Current status.
    Wilke WS; Mackenzie AH
    Drugs; 1986 Aug; 32(2):103-13. PubMed ID: 3743465
    [No Abstract]   [Full Text] [Related]  

  • 70. Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al.
    Fries JF; Ramey DR; Singh G
    Arthritis Rheum; 1994 Dec; 37(12):1829-30. PubMed ID: 7986233
    [No Abstract]   [Full Text] [Related]  

  • 71. Absorption of methotrexate and hepatotoxicity.
    Dubin HV; Harrell ER
    JAMA; 1969 Nov; 210(6):1104. PubMed ID: 5394437
    [No Abstract]   [Full Text] [Related]  

  • 72. Low-dose methotrexate therapy and hepatotoxicity.
    Korman MG
    Med J Aust; 1992 Feb; 156(3):221. PubMed ID: 1545730
    [No Abstract]   [Full Text] [Related]  

  • 73. Creating a care-effective cost-effective strategy for methotrexate liver toxicity monitoring in rheumatoid arthritis: comment on the article by Kremer et al.
    Newman ED; Harrington TM; Perruquet JL; Davis DE; Torretti D
    Arthritis Rheum; 1995 Feb; 38(2):297-8. PubMed ID: 7848325
    [No Abstract]   [Full Text] [Related]  

  • 74. Methotrexate hepatotoxicity in psoriasis.
    Ryan TJ; Sadler GH; Guerrier C; Vickers HR
    Br Med J; 1972 Apr; 2(5808):296. PubMed ID: 5022031
    [No Abstract]   [Full Text] [Related]  

  • 75. Oral methotrexate.
    Taylor JR; Halprin KM; Schiff ER
    Dig Dis Sci; 1986 Apr; 31(4):443-5. PubMed ID: 3956342
    [No Abstract]   [Full Text] [Related]  

  • 76. [Practical aspects of the cytostatic therapy of psoriasis].
    Rassner G
    Z Hautkr; 1976 Jun; 51(12):499-506. PubMed ID: 60007
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Liver biopsies and methotrexate: a time for reconsideration?
    Chalmers RJ; Boffa MJ; Kirby B; Smith A
    J Am Acad Dermatol; 2001 May; 44(5):879-80. PubMed ID: 11312452
    [No Abstract]   [Full Text] [Related]  

  • 78. Cyclosporine and methotrexate: a dangerous combination.
    Korstanje MJ; van Breda Vriesman CJ; van de Staak WJ
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):320-1. PubMed ID: 2212132
    [No Abstract]   [Full Text] [Related]  

  • 79. Letter: Liver disease in psoriatics.
    Yaffee HS
    Arch Dermatol; 1975 Apr; 111(4):524-5. PubMed ID: 1122155
    [No Abstract]   [Full Text] [Related]  

  • 80. Experiences with methotrexate in psoriasis.
    Frank L; Lichtman H; Biro L; Petrou P
    Dermatologica; 1968; 137(2):87-96. PubMed ID: 5668252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.